Literature DB >> 32363620

Prevalence of coeliac disease in Northwest China: heterogeneity across Northern Silk road ethnic populations.

Chunyan Zhou1,2, Feng Gao3, Jinyan Gao2, Juanli Yuan4, Jiajie Lu3, Zhenzhu Sun5, Mengyu Xu1,2, Jasper Engel6, Wenjia Hui3, Luud Gilissen7, Hongbing Chen1,8.   

Abstract

BACKGROUND: Epidemiological data of coeliac disease are lacking from the central Asian region. AIMS: To verify the occurrence of coeliac disease amongst four major ethnic groups of Xinjiang Uyghur Autonomus Region, China.
METHODS: 2277 in-patients with gastrointestinal symptoms (1391 Han, 608 Uyghur, 146 Kazakh and 132 Hui; mean age: 54 ± 12.8 years) were included. Total IgA, anti-deamidated gliadin peptide (DGP)-IgG, and anti-tissue transglutaminase (anti-tTG)-IgA were analysed. All antibody-positive subjects were further tested for endomysial (EMA) antibodies and were HLA genotyped. All subjects with antibody positivity were asked to undergo intestinal biopsy. In addition, a subset of antibody-negative subjects were tested for HLA-DQA1and DQB1.
RESULTS: Among the 2277 subjects, 29 subjects were defined as coeliac disease autoimmune (positive results for anti-tTG IgA and EMA-IgA) (1.27%; 95% confidence interval, 0.81%-1.73%), eight of them underwent biopsy and all showed coeliac disease histology (0.35%; 95% Cl, 0.11%-0.59%). The frequency of coeliac disease autoimmunity was lowest among the Han (0.79%), followed by the Uyghur (1.81%), the Kazakh (2.05%) and the Hui (3.03%). The frequency of the HLA-DQ2 and/or DQ8 haplotype was highest in the Uyghur (52.1%), followed by the Hui (44.4%), the Kazakh (40.0%) and the Han (39.4%). Besides, a three times higher frequency of coeliac disease autoimmunity was found among rural living subjects with significantly higher wheat consumption compared to urban living subjects (3.16% vs 0.97%, P < 0.01).
CONCLUSIONS: In Xinjiang, coeliac disease does occur, especially in the rural area. The HLA haplotype and environment play key roles in the development of coeliac disease.
© 2020 John Wiley & Sons Ltd.

Entities:  

Year:  2020        PMID: 32363620     DOI: 10.1111/apt.15737

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  6 in total

Review 1.  The global burden of coeliac disease: opportunities and challenges.

Authors:  Govind K Makharia; Prashant Singh; Carlo Catassi; David S Sanders; Daniel Leffler; Raja Affendi Raja Ali; Julio C Bai
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-01-03       Impact factor: 46.802

2.  Wheat Amylase Trypsin Inhibitors Aggravate Intestinal Inflammation Associated with Celiac Disease Mediated by Gliadin in BALB/c Mice.

Authors:  Tian Yu; Shuai Hu; Fangfang Min; Jingjing Li; Yunpeng Shen; Juanli Yuan; Jinyan Gao; Yong Wu; Hongbing Chen
Journal:  Foods       Date:  2022-05-25

Review 3.  Celiac Disease: Fallacies and Facts.

Authors:  Jocelyn A Silvester; Amelie Therrien; Ciaran P Kelly
Journal:  Am J Gastroenterol       Date:  2021-06-01       Impact factor: 12.045

4.  Underutilization of diagnostic assays for celiac disease in Korea.

Authors:  Rihwa Choi; Sang Gon Lee; Eun Hee Lee
Journal:  J Clin Lab Anal       Date:  2021-10-24       Impact factor: 2.352

5.  Celiac disease in the COVID-19 pandemic.

Authors:  Gabriel Samasca; Aaron Lerner
Journal:  J Transl Autoimmun       Date:  2021-08-31

6.  Epidemiological, clinical, and histological presentation of celiac disease in Northwest China.

Authors:  Man Wang; Wen-Jie Kong; Yan Feng; Jia-Jie Lu; Wen-Jia Hui; Wei-Dong Liu; Zi-Qiong Li; Tian Shi; Mei Cui; Zhen-Zhu Sun; Feng Gao
Journal:  World J Gastroenterol       Date:  2022-03-28       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.